Replies to post #2509 on Gilead Sciences Inc (GILD)

[north40000]

Thanks, but still no reference to any age limitation for which PRV may be used.

"For Gilead, the voucher could be used to speed review for one of its several late-stage candidates. The $125 million is a relative bargain as well, compared to both the recent prices paid by Sanofi and AbbVie as well as to Gilead's large cash hoard."